Clinical Trial Update: A Research Study of the New Medicine NNC0519-0130 in Male Chinese Participants Living With Excess Body Weight [Phase 1]

View source ↗

Summary

Phase 1 study of NNC0519-0130 in male Chinese participants living with excess body weight has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0519-0130

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2, Obesity | Phase 1 | Status: COMPLETED